Exact Mass: 664.4961

Exact Mass Matches: 664.4961

Found 110 metabolites which its exact mass value is equals to given mass value 664.4961, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(16:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(16:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0)

(2S)-3-(hexadecanoyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGE2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H68O8 (664.4914)

DG(PGD2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C39H68O8 (664.4914)

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0)

(2S)-2-hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

3-[[7alpha-Hydroxy-24-oxo-3beta-[[3-[(4-aminobutyl)amino]propyl]amino]-5alpha-cholestane-26-yl]thio]-2-aminopropanoic acid

C37H68N4O4S (664.4961)

DG(16:0/PGE2/0:0)

C39H68O8 (664.4914)

DG(PGE2/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/PGE2)

C39H68O8 (664.4914)

DG(PGE2/0:0/16:0)

C39H68O8 (664.4914)

DG(16:0/PGD2/0:0)

C39H68O8 (664.4914)

DG(PGD2/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/PGD2)

C39H68O8 (664.4914)

DG(PGD2/0:0/16:0)

C39H68O8 (664.4914)

DG(i-16:0/PGE2/0:0)

C39H68O8 (664.4914)

DG(PGE2/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGE2)

C39H68O8 (664.4914)

DG(PGE2/0:0/i-16:0)

C39H68O8 (664.4914)

DG(i-16:0/PGD2/0:0)

C39H68O8 (664.4914)

DG(PGD2/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/PGD2)

C39H68O8 (664.4914)

DG(PGD2/0:0/i-16:0)

C39H68O8 (664.4914)

DG(16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/16:0/0:0)

C39H68O8 (664.4914)

DG(16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/16:0)

C39H68O8 (664.4914)

DG(i-16:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-16:0/0:0)

C39H68O8 (664.4914)

DG(i-16:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C39H68O8 (664.4914)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-16:0)

C39H68O8 (664.4914)

2-[hydroxy-[(2R)-2-nonanoyloxy-3-octadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

NAGlySer 16:1/17:1

C38H68N2O7 (664.5026)

NAGlySer 11:0/22:2

C38H68N2O7 (664.5026)

NAGlySer 16:2/17:0

C38H68N2O7 (664.5026)

NAGlySer 17:2/16:0

C38H68N2O7 (664.5026)

NAGlySer 14:1/19:1

C38H68N2O7 (664.5026)

NAGlySer 13:0/20:2

C38H68N2O7 (664.5026)

NAGlySer 20:1/13:1

C38H68N2O7 (664.5026)

NAGlySer 18:2/15:0

C38H68N2O7 (664.5026)

NAGlySer 19:1/14:1

C38H68N2O7 (664.5026)

NAGlySer 18:1/15:1

C38H68N2O7 (664.5026)

NAGlySer 15:1/18:1

C38H68N2O7 (664.5026)

NAGlySer 19:2/14:0

C38H68N2O7 (664.5026)

NAGlySer 14:0/19:2

C38H68N2O7 (664.5026)

NAGlySer 16:0/17:2

C38H68N2O7 (664.5026)

NAGlySer 21:2/12:0

C38H68N2O7 (664.5026)

NAGlySer 17:1/16:1

C38H68N2O7 (664.5026)

NAGlySer 22:2/11:0

C38H68N2O7 (664.5026)

NAGlySer 17:0/16:2

C38H68N2O7 (664.5026)

NAGlySer 13:1/20:1

C38H68N2O7 (664.5026)

NAGlySer 12:0/21:2

C38H68N2O7 (664.5026)

NAGlySer 20:2/13:0

C38H68N2O7 (664.5026)

NAGlySer 15:0/18:2

C38H68N2O7 (664.5026)

2-[[(2R)-3-dodecanoyloxy-2-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[hydroxy-[(2R)-2-tetradecanoyloxy-3-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[hydroxy-[(2R)-3-tetradecanoyloxy-2-tridecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2R)-2-dodecanoyloxy-3-pentadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

[O-(1-O-Undecanoyl-2-O-hexadecanoyl-L-glycero-3-phospho)choline]anion

C35H71NO8P+ (664.4917)

2-[[(2S)-3-hexadecanoyloxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Decanoyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Hexadecanoyloxy-3-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Dodecanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(2-tetradecanoyloxy-3-tridecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(2-nonadecanoyloxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(3-nonanoyloxy-2-octadecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2S)-2-decanoyloxy-3-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[[(2R)-3-decanoyloxy-2-heptadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Butanoyloxy-2-tricosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Heptanoyloxy-2-icosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Docosanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[Hydroxy-(3-propanoyloxy-2-tetracosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(2-Henicosanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

2-[(3-Acetyloxy-2-pentacosanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H71NO8P+ (664.4917)

(1r)-1-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

1-hydroxy-1-[5-(1-hydroxytridecyl)oxolan-2-yl]-15-(5-methyl-2-oxo-5h-furan-3-yl)-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

(1r,3s)-1-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-8-oxopentadecan-3-yl acetate

C39H68O8 (664.4914)

3-hydroxy-1-[5-(1-hydroxytridecyl)oxolan-2-yl]-15-(5-methyl-2-oxo-5h-furan-3-yl)-13-oxopentadecyl acetate

C39H68O8 (664.4914)

3-{[(6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

3-{[(6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

C37H68N4O4S (664.4961)

(2s,4s,6s,8s,10z,12r,14r,16e,18s,19s)-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

(1r,3s)-3-hydroxy-1-[(2r,5r)-5-[(1s)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-13-oxopentadecyl acetate

C39H68O8 (664.4914)

(2r)-3-{[(2s,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

(2r)-3-{[(2s,6r)-6-[(1r,3as,3br,4r,5ar,7s,9as,9bs,11ar)-7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl]sulfanyl}-2-aminopropanoic acid

C37H68N4O4S (664.4961)

11,19-dihydroxy-20-[5'-(1-hydroxyethyl)-2,5'-dimethyl-[2,2'-bioxolan]-5-yl]-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

(2s,4s,6s,8s,12r,14r,18s,19s)-11,19-dihydroxy-20-{5'-[(1r)-1-hydroxyethyl]-2,5'-dimethyl-[2,2'-bioxolan]-5-yl}-2,4,6,8,12,14,18-heptamethyl-9-oxoicosa-10,16-dienoic acid

C39H68O8 (664.4914)

2-amino-3-({6-[7-({3-[(4-aminobutyl)amino]propyl}amino)-4-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-oxoheptyl}sulfanyl)propanoic acid

C37H68N4O4S (664.4961)

(1r,3r)-3-hydroxy-1-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]-15-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]-13-oxopentadecyl acetate

C39H68O8 (664.4914)